Yes, for many women.

Odds of high anxiety were elevated during and after the menopausal transition compared with premenopause, with the clearest effect in women who had low anxiety before the transition started. Panic attacks are also common around this life stage: in one large study, about 1 in 6 postmenopausal women reported a panic attack over a 6-month period. This does not mean anxiety is 'just' hormonal; life stressors and health comorbidities at this age matter too, but the transition itself appears to raise risk independent of a stable anxious personality.

What to know about this answer

There is broad agreement that anxiety risk rises around the transition specifically for previously low-anxiety women. The more open question is how much of that rise reflects the hormonal transition itself versus the life-stage stressors, such as health and family demands, that cluster at the same age.

What the research shows, and which source each finding rests on

In a 10-year SWAN study of 2,956 women, odds of high anxiety were elevated during and after the menopausal transition relative to premenopause, with the clearest stage effect in women who had low anxiety at baseline; women with high baseline anxiety stayed anxious regardless of stage

In a Women's Health Initiative ancillary study of 3,369 women aged 50-79, the 6-month prevalence of any panic attack was 17.9 percent (9.8 percent full-blown, 8.1 percent limited-symptom), associated with stressful life events, medical comorbidity, and functional impairment

Where the real disagreement is

Each position is shown with its own sources. A position listed here is not necessarily the accepted view.

Transition-linked, not just life stage or personality

Bromberger and the SWAN investigators

The SWAN data show a stage-specific effect distinct from a stable anxious-personality group, since women with previously low anxiety, not just those already anxious, saw a rise tied to the transition; the panic-attack study likewise ties prevalence partly to comorbidity and stressful life events rather than hormones alone.

What would settle it: Studies that separate hormone-flux measures from concurrent life-stress measures within the same women, to weigh their relative contributions to new-onset anxiety.

What is really going on here

  1. Was my anxiety history taken before my current symptoms were attributed to hormones or dismissed as stress? Attributing everything to menopause can delay real treatment, and attributing everything to psychiatry can miss a hormone-sensitivity pattern.
  2. For anxiety and irritability, has anyone asked about my sleep? Vasomotor symptoms and sleep fragmentation are a checkable, treatable path to mood symptoms.

Questions for your doctor

  1. Is this new anxiety, or an intensification of anxiety I've had before?
  2. Could my sleep, hot flashes, or life stressors be contributing to this?
  3. What treatment options exist: therapy, medication, or hormone therapy?
  4. Should I be screened specifically for panic attacks, not just general anxiety?

Questions with no answer yet

In the women whose anxiety rose only during the transition, not the already-anxious group, does that anxiety resolve on its own after menopause the way the cognitive dip does, or does it persist?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: The SWAN data show a stage-specific anxiety rise concentrated in previously low-anxiety women, but there is no report of whether this group was followed long enough after the transition to see if anxiety returns to premenopausal levels, unlike the cognitive rebound finding covered elsewhere in this file.

What would test it: Long-term follow-up of the low-baseline-anxiety group well into postmenopause to see whether their anxiety returns to premenopausal levels.

How much of the elevated panic-attack prevalence in this age group is explained by hormones directly, versus by the medical comorbidity and stressful life events the same study found were associated with it?

Partly studied

What is known: The panic-attack study found prevalence associated with stressful life events, medical comorbidity, and functional impairment, alongside the age and menopause association, but did not statistically separate how much each factor contributes independent of the others.

What would test it: A study modeling hormone status, life stress, and comorbidity together to estimate each factor's independent contribution to panic-attack risk.

Would treating vasomotor symptoms and sleep fragmentation directly reduce new-onset anxiety, given how tightly those symptoms are already linked to mood in this population?

Not directly studied yet

No research does not mean it does not work, and it does not mean it works. It means nobody has tested it yet.

What is known: Vasomotor symptoms and sleep fragmentation are described as a checkable, treatable path to mood symptoms generally, but no trial specifically tests whether treating hot flashes and sleep reduces new-onset anxiety as a primary outcome.

What would test it: A trial of vasomotor symptom treatment with new-onset anxiety as a pre-specified outcome measure.

Sources

  1. 1.Does risk for anxiety increase during the menopausal transition? Study of women's health across the nation.Bromberger JT et al., Menopause 2013 · Observational study
  2. 2.Prevalence and correlates of panic attacks in postmenopausal women: results from an ancillary study to the Women's Health Initiative.Smoller JW et al., Arch Intern Med 2003 · Comparative or small study

The letter grades the type of study behind a claim, not the answer itself.

This page is general information based on published research and public sources. It is not medical advice and not a personal assessment, and it does not replace a conversation with your doctor. Peritale is a wellness product, not a medical device, and is not intended to diagnose, treat, cure or prevent any disease. For any medical question, speak with a licensed clinician.

You are not imagining it

In about seven minutes on your phone, Peritale reads five signal systems and maps your symptoms, so you can see that what you feel is real, follow your hormonal transition over time, and walk into your doctor ready to ask for the care you deserve. Your first check is free, no credit card.

Start Free Mapping

Related questions

Related guides